Does CLADRIBINE Cause Second primary malignancy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with CLADRIBINE (Cladribine). This represents 0.1% of all adverse event reports for CLADRIBINE.
5
Reports of Second primary malignancy with CLADRIBINE
0.1%
of all CLADRIBINE reports
2
Deaths
1
Hospitalizations
How Dangerous Is Second primary malignancy From CLADRIBINE?
Of the 5 reports, 2 (40.0%) resulted in death, 1 (20.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLADRIBINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CLADRIBINE Cause?
Fatigue (696)
Headache (579)
Lymphocyte count decreased (448)
Multiple sclerosis relapse (404)
Nausea (354)
Pneumonia (318)
White blood cell count decreased (311)
Urinary tract infection (242)
Pyrexia (207)
Multiple sclerosis (206)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which CLADRIBINE Alternatives Have Lower Second primary malignancy Risk?
CLADRIBINE vs CLARAVIS
CLADRIBINE vs CLARITHROMYCIN
CLADRIBINE vs CLARITIN
CLADRIBINE vs CLARITIN CHEWABLE
CLADRIBINE vs CLARITIN-D-12